torpedo has been researched along with transforming growth factor beta in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, S; Li, H; Link, H; Ljunggren, HG; Shi, FD; Taniguchi, M; Van Kaer, L; Wang, HB | 1 |
Mozes, E; Paas-Rozner, M; Sela, M | 1 |
Duan, RS; Link, H; Scallon, B; Wang, HB; Xiao, BG; Yang, JS | 1 |
Aruna, BV; Mozes, E; Sela, M | 1 |
Ben-David, H; Dayan, M; Mozes, E; Sela, M; Sharabi, A | 1 |
5 other study(ies) available for torpedo and transforming growth factor beta
Article | Year |
---|---|
Natural killer cells determine the outcome of B cell-mediated autoimmunity.
Topics: Amino Acid Sequence; Animals; Antibody Formation; Autoantibodies; Autoimmunity; B-Lymphocytes; Female; Immunization; Inbreeding; Interferon-gamma; Interleukin-8; Killer Cells, Natural; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Myasthenia Gravis, Autoimmune, Experimental; Receptors, Nicotinic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta | 2000 |
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.
Topics: Amino Acid Sequence; Animals; Cytokines; Female; Immunization; Interleukin-2; Interleukin-4; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Myasthenia Gravis; Peptide Fragments; Receptors, Cholinergic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta | 2001 |
Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis.
Topics: Animals; Antibodies; Disease Models, Animal; Down-Regulation; Female; Interferon-gamma; Interleukin-10; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Receptors, Nicotinic; T-Lymphocytes; Torpedo; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells.
Topics: Animals; Autoimmunity; Biomarkers; CD4-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Down-Regulation; Female; Immunosuppression Therapy; Interleukin-10; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myasthenia Gravis, Autoimmune, Experimental; Peptides; Receptors, Interleukin-2; Receptors, Nicotinic; Subcellular Fractions; Torpedo; Transforming Growth Factor beta; Treatment Outcome; Up-Regulation | 2006 |
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.
Topics: Animals; bcl-X Protein; Caspase 3; Caspase 8; CD28 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Proliferation; Cells, Cultured; Down-Regulation; Female; Forkhead Transcription Factors; Immunization; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Ligands; Mice; Mice, Knockout; Myasthenia Gravis; Peptides; Receptors, Nicotinic; Torpedo; Transforming Growth Factor beta; Up-Regulation | 2007 |